Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to eight years before mammography. The company is also focused on research and development efforts that may enable the commercialization of treatments for pre-cancerous lesions. Atossa Genetics is based in Seattle, Wash. For more information, visit the company’s Web site at www.atossagenetics.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: